THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT TYLER
TYLER, Texas
Total Received
$72.3M
Total Awards
53
State
Texas
Last Updated
Mar 27, 2026
Yearly Funding Trend
$65.0M24
$7.3M25
$13K26
Top 50 Awards to THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT TYLER
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 27, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_U54OH007541_075 SOUTHWEST CENTER FOR AGRICULTURAL HEALTH, INJURY PREVENTION, AND EDUCATION | Department of Health and Human Services Centers for Disease Control and Prevention | 93.262 OCCUPATIONAL SAFETY AND HEALTH PROGRAM | TYLER COUNTY, TX | 2024 | $22,446,209 |
ASST_NON_R01HL130402_075 DELIVERY OF PAI-1-TARGETED INTRAPLEURAL FIBRINOLYTIC THERAPY FOR EMPYEMA - EMPYEMA IS A BACTERIAL INFECTION OF THE PLEURAL SPACE, A SERIOUS COMPLICATION OF PNEUMONIA THAT CARRIES… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | TYLER, TX-01 | 2024 | $3,755,486 |
ASST_NON_R01HL124055_075 MEMBRANE PHOSPHOLIPIDS: THE KEY REGULATORS OF TISSUE FACTOR ENCRYPTION/DECRYPTION - UPON VASCULAR INJURY, PLASMA CLOTTING FACTOR VII (FVII) ALONG WITH TRACES OF ACTIVATED FVII (FV… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | TX-90 | 2024 | $3,278,132 |
ASST_NON_R01AI142672_075 INNATE IMMUNE RESPONSE OF LTBI+HIV+ CHILDREN - MYCOBACTERIUM TUBERCULOSIS (MTB) INFECTS ONE-THIRD OF THE WORLD’S POPULATION AND CAUSES ALMOST 1.3 MILLION DEATHS PER YEAR, INCLUDIN… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | MO-90 | 2024 | $2,835,210 |
ASST_NON_R01HL152059_075 ENHANCED DELIVERY OF THROMBOLYTIC CARRIERS FOR EMPYEMA - PROJECT SUMMARY EMPYEMA (EMP) IS INCREASING IN FREQUENCY WORLDWIDE AND IS ASSOCIATED WITH A MORTALITY RATE OF UP TO 20% IN… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | TYLER, TX-01 | 2024 | $2,499,662 |
ASST_NON_T03OH009221_075 INNOVATIVE TRAINING EXPERIENCES FOR OCC MED RESIDENTS IN NON-URBAN & AG SETTINGS | Department of Health and Human Services Centers for Disease Control and Prevention | 93.262 OCCUPATIONAL SAFETY AND HEALTH PROGRAM | TX-90 | 2024 | $2,369,656 |
ASST_NON_UG3AI150550_075 NOVEL CRISPR-CAS9 PROTEIN DELIVERY TO T CELLS IN VIVO BY TARGETING CD7 - ABSTRACT THE GOAL OF THIS PROPOSED RESEARCH IS TO OPTIMIZE THE CRISPR-CAS9 DELIVERY SYSTEM FOR EFFICIENT I… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | TX-90 | 2025 | $2,065,311 |
ASST_NON_D4033375_075 GRADUATE PSYCHOLOGY EDUCATION PROGRAMS | Department of Health and Human Services Health Resources and Services Administration | 93.191 GRADUATE PSYCHOLOGY EDUCATION | TX-90 | 2024 | $2,055,549 |
ASST_NON_R01HL169255_075 FACTOR VIIA-RELEASED EXTRACELLULAR VESICLES: THEIR ROLE IN HEMOSTASIS AND BEYOND - CLOTTING FACTOR VIIA (FVIIA) INITIATES THE ACTIVATION OF THE COAGULATION CASCADE BY BINDING TO T… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | TYLER, TX-01 | 2024 | $2,002,485 |
ASST_NON_R01HL144610_075 ENDOTHELIAL MECHANISM IN RIPC - REMOTE ISCHEMIC PRECONDITIONING (RIPC) IS A CLINICALLY EFFECTIVE AND NON-INVASIVE ISCHEMIA-REPERFUSION (I/R) OF A REMOTE ORGAN THAT PROVIDES SIGNIF… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | LUBBOCK, TX-19 | 2024 | $1,929,076 |
ASST_NON_R01HL142853_075 MYOCARDIN IN THE PATHOGENESIS OF PLEURAL REMODELING - PLEURAL INJURY OFTEN LEADS TO EXTENSIVE REMODELING OF THE PLEURAL SURFACES, WHICH IN SEVERE CASES LEADS TO PLEURAL FIBROSIS (… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | TX-90 | 2025 | $1,857,147 |
ASST_NON_R01HL130133_075 FIBRINOLYTIC PROTEASES, MESO-MESENCHYMAL TRANSITION AND PLEURAL REMODELING - PLEURAL INJURY OFTEN RESOLVES WITH REMODELING OF THE PLEURAL SURFACES, WHICH IN SEVERE CASES LEADS TO… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | TYLER, TX-01 | 2024 | $1,812,500 |
ASST_NON_R01HL151397_075 DEVELOPMENT, FORMULATION AND INHALATIONAL DELIVERY OF A NEW PEPTIDE FOR ILD - INTERSTITIAL LUNG DISEASES (ILDS) ARE CHARACTERIZED BY PROGRESSIVE PULMONARY SCARRING. IDIOPATHIC PUL… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | TX-90 | 2024 | $1,796,712 |
ASST_NON_R01AI179827_075 SHORT COURSE COMBINATION REGIMENS FOR TREATMENT OF MYCOBACTERIUM AVIUM PULMONARY DISEASE: A TRANSLATIONAL BENCH-TO-BEDSIDE APPROACH - PROJECT SUMMARY NONTUBERCULOUS MYCOBACTERIA (… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TYLER, TX-01 | 2024 | $1,691,972 |
ASST_NON_DEAU0000048_089 PANTEX FORMER WORKER MEDICAL SURVEILLANCE PROGRAM | Department of Energy Department of Energy | 81.108 EPIDEMIOLOGY AND OTHER HEALTH STUDIES FINANCIAL ASSISTANCE PROGRAM | TYLER, TX-01 | 2024 | $1,500,000 |
ASST_NON_R01HL166906_075 RUNX3 IN VASCULAR WALL REMODELING - PROJECT SUMMARY VASCULAR SMOOTH MUSCLE CELL (VSMC) PHENOTYPIC MODULATION, A PHENOTYPIC SWITCH FROM A DIFFERENTIATED CONTRACTILE PHENOTYPE TO A… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | TYLER, TX-01 | 2024 | $1,351,070 |
ASST_NON_R01AI181600_075 PROBING REAL-TIME CONFORMATIONAL DYNAMICS AND ALLOSTERIC COOPERATIVITY OF THE HIV-1 ENVELOPE GLYCOPROTEIN DURING VIRUS ENTRY - PROJECT SUMMARY: THE ENVELOPE (ENV) GLYCOPROTEIN EXP… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TYLER, TX-01 | 2024 | $1,315,638 |
ASST_NON_R01HL170945_075 THE ROLE OF GAB2-MALT1-MEDIATED CELL SIGNALING IN VENOUS THROMBOGENESIS - VENOUS THROMBOEMBOLISM (VTE), WHICH COMPRISES DEEP VEIN THROMBOSIS (DVT) AND PULMONARY EMBOLISM (PE), IS… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | TYLER, TX-01 | 2024 | $1,227,432 |
ASST_NON_R35GM151169_075 THE ROLE OF CONFORMATIONAL DYNAMICS OF ENVELOPED VIRUS SPIKE PROTEINS IN CELL ENTRY - RESEARCH ABSTRACT: THE SPIKE/FUSION GLYCOPROTEINS RESIDING ON THE SURFACE OF HUMAN ENVELOPED… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | TYLER, TX-01 | 2024 | $1,117,500 |
ASST_NON_GA145988_075 RURAL COMMUNITIES OPIOID RESPONSE-IMPLEMENTATION - TITLE: ANDERSON AND CHEROKEE COUNTIES OPIOID RESPONSE (ANCHOR): BUILDING AND ENHANCING A CASCADE OF CARE FOR OPIOID AND OTHER SU… | Department of Health and Human Services Health Resources and Services Administration | 93.912 RURAL HEALTH CARE SERVICES OUTREACH, RURAL HEALTH NETWORK DEVELOPMENT AND SMALL HEALTH CARE PROVIDER QUALITY IMPROVEMENT | TX-90 | 2024 | $1,000,000 |
ASST_NON_GA139612_075 RURAL COMMUNITIES OPIOID RESPONSE-IMPLEMENTATION | Department of Health and Human Services Health Resources and Services Administration | 93.211 TELEHEALTH PROGRAMS | TX-90 | 2024 | $957,941 |
ASST_NON_R33HL154103_075 OPTIMIZATION OF A RABBIT RETAINED HEMOTHORAX MODEL FOR EVIDENCE-BASED PHARMACOLOGIC INTERVENTIONS - ABSTRACT RETAINED HEMOTHORAX IS A COMPLICATION OF BLEEDING INTO THE PLEURAL SPA… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | TYLER, TX-01 | 2024 | $881,243 |
ASST_NON_W81XWH2210450_097 FOCAL ADHESION KINASE INHIBITION AS A NOVEL THERAPEUTIC STRATEGY FOR LARYNGEAL SQUAMOUS CELL CARCINOMA TRANSFER OF AWARD 2. PER SECTION 711 OF THE NATIONAL DEFENSE AUTHORIZATION A… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | TYLER, TX-01 | 2025 | $880,000 |
ASST_NON_R01HL171576_075 D0CK2 IN PLEURAL FIBROSIS-DIVERSITY SUPPLEMENT - PLEURAL FIBROSIS IS THE SCARRING OF THE PLEURA RESULTING IN RESTRICTIVE LUNG DISEASE AND IMPAIRED LUNG FUNCTION. THE PATHOPHYSIOLO… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | TYLER, TX-01 | 2024 | $841,469 |
ASST_NON_D3349093_075 PREVENTIVE MEDICINE RESIDENCY | Department of Health and Human Services Health Resources and Services Administration | 93.117 PREVENTIVE MEDICINE RESIDENCY | TX-90 | 2024 | $802,657 |
ASST_NON_R00HL141583_075 DEDICATOR OF CYTOKINESIS 2 IN ATHEROSCLEROSIS - ATHEROSCLEROSIS, THE MAJOR COMMON RISK FACTOR OF CORONARY ARTERY DISEASE AND STROKE, IS THE PRIMARY CAUSE OF DEATH PARTICULARLY IN… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | TX-90 | 2024 | $747,604 |
ASST_NON_UL853325_075 INTEGRATING BEHAVIORAL HEALTH INTO PRIMARY CARE THROUGH TELEHEALTH EVIDENCE-BASED TELEHEALTH NETWORK | Department of Health and Human Services Health Resources and Services Administration | 93.211 TELEHEALTH PROGRAMS | TX-90 | 2024 | $700,000 |
ASST_NON_P1333182_075 RURAL RESIDENCY PLANNING AND DEVELOPMENT PROGRAM | Department of Health and Human Services Health Resources and Services Administration | 93.211 RURAL TELEMEDICINE GRANTS | TX-90 | 2024 | $690,333 |
ASST_NON_R61HL175690_075 CONCURRENT TARGETING OF INFLAMMATION AND THE INHIBITION OF THE FIBRINOLYTIC SYSTEM TO INCREASE THE EFFICACY OF EMPYEMA TREATMENT - ABSTRACT: THE INCIDENCE AND MORTALITY OF EMPYEMA… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | TX-90 | 2025 | $499,585 |
ASST_NON_NU58DP007248_075 BRINGING A HEALTH EQUITY FRAMEWORK TO THE TEXAS PERINATAL QUALITY COLLABORATIVE TO ELIMINATE DISPARITIES IN PERINATAL HEALTH - CDC-RFA-DP22-2207 (COMPONENT A) TEXAS IS AMONG… | Department of Health and Human Services Centers for Disease Control and Prevention | 93.946 COOPERATIVE AGREEMENTS TO SUPPORT STATE-BASED SAFE MOTHERHOOD AND INFANT HEALTH INITIATIVE PROGRAMS | TX-90 | 2024 | $449,177 |
ASST_NON_R21AI148096_075 REINFORCING OLD WARRIORS TO TREAT MYCOBACTERIUM KANSASII IN SHORTER DURATION - PROJECT SUMMARY MYCOBACTERIUM KANSASII (M. KANSASII) IS THE SECOND MOST COMMON NON-TUBERCULOUS MYCOB… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TYLER, TX-01 | 2024 | $412,862 |
ASST_NON_R21AI180922_075 ROLE OF RUNX3 IN THE REGULATION OF LUNG CDC2 BY INFLUENZA INFECTION - PROJECT SUMMARY: RESPIRATORY VIRUSES SUCH AS INFLUENZA AND SARS-COV-2 POSE A CONTINUING AND SUBSTANTIVE THREA… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TYLER, TX-01 | 2024 | $409,750 |
ASST_NON_R21AI171587_075 DISTINCT RESPONSES OF LUNG MACROPHAGES AND AIRWAY EPITHELIAL CELLS TO HAWAI'I-DERIVED VOLCANIC ASH AND NONTUBERCULOUS MYCOBACTERIA - PROJECT SUMMARY/ABSTRACT NONTUBERCULOUS MYCOBA… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TYLER, TX-01 | 2024 | $408,250 |
ASST_NON_R21AI163608_075 TISSUE FACTOR'S ROLE IN THE PATHOGENESIS OF HYPERCOAGULABILITY IN COVID-19 - EMERGING EVIDENCE INDICATES THAT THE NOVEL SARS-COV-2 INFECTION IS ASSOCIATED WITH A HIGH INCIDENCE OF… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TX-90 | 2025 | $404,250 |
ASST_NON_R21AI163558_075 THE ROLE OF GAB2 SIGNALING IN THROMBOINFLAMMATION - INFLAMMATION IS A PROTECTIVE RESPONSE OF THE ORGANISM TO FIGHT AGAINST INVADING PATHOGENS OR ENDOGENOUS DANGER SIGNALS SUCH AS… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TX-90 | 2025 | $404,250 |
ASST_NON_M0154889_075 BEHAVIORAL HEALTH WORKFORCE EDUCATION AND TRAINING PROGRAM - PROJECT ABSTRACT BEHAVIORAL HEALTH EXPANSION IN NORTHEAST TEXAS THROUGH INTEGRATED CARE EDUCATION THE UNIVERSITY OF… | Department of Health and Human Services Health Resources and Services Administration | 93.732 MENTAL AND BEHAVIORAL HEALTH EDUCATION AND TRAINING GRANTS | TX-90 | 2025 | $377,253 |
ASST_NON_R56HL163554_075 DEDICATOR OF CYTOKINESIS 2 IN PLEURAL FIBROSIS - PLEURAL FIBROSIS IS THE SCARRING OF THE PLEURA RESULTING IN RESTRICTIVE LUNG DISEASE AND IMPAIRED LUNG FUNCTION. THE PATHOPHYSIOLO… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | TYLER, TX-01 | 2024 | $362,800 |
ASST_NON_K24HL166681_075 CHARACTERIZATION OF MECHANISMS OF EXERCISE INTOLERANCE IN PATIENTS AT RISK FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION - PROJECT SUMMARY (30 LINES) DR. JARETT BERRY IS A PR… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | TX-90 | 2024 | $344,635 |
ASST_NON_R56AI170101_075 PROBING CONFORMATIONAL DYNAMICS OF HIV-1 ENV IN REAL TIME AND IN SITU DURING VIRUS ENTRY - RESEARCH ABSTRACT: THE ENVELOPE (ENV) GLYCOPROTEIN IS A VIRUS-ENCODED PROTEIN EXPOSED ON… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TX-90 | 2025 | $343,617 |
ASST_NON_U01OH011926_075 IMPROVING CREW OVERBOARD RECOVERY FOR COMMERCIAL FISHING VESSELS IN THE GULF OF MEXICO | Department of Health and Human Services Centers for Disease Control and Prevention | 93.262 OCCUPATIONAL SAFETY AND HEALTH PROGRAM | TX-90 | 2024 | $325,000 |
ASST_NON_W81XWH2010142_097 ROLE OF P53 AND PAI-1 IN TOBACCO SMOKE-INDUCED LUNG INJURY | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | TYLER, TX-01 | 2024 | $248,314 |
ASST_NON_R21CA282561_075 CSP7 INHIBITS TOXICITY OF IONIZING RADIATION TO THE LUNG - RADIATION THERAPY IS THE MAINSTAY IN THE TREATMENT OF LUNG, BREAST AND ESOPHAGEAL CANCERS, TYPES OF LYMPHOMA AND TUMORS… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | TX-90 | 2025 | $219,024 |
ASST_NON_W81XWH2110095_097 DEVELOPMENT OF A NOVEL DRUG CANDIDATE, CSP7, FOR THE TREATMENT OF COVID-19 DE-OBLIGATE FUNDS TO CLOSE AWARD | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | TYLER, TX-01 | 2025 | $213,649 |
ASST_NON_R21ES032506_075 REGULATION OF SILICA-INDUCED LUNG INJURY BY PLASMINOGEN ACTIVATOR INHIBITOR-1 - OCCUPATIONAL OR ENVIRONMENTAL EXPOSURE TO RESPIRABLE CRYSTALLINE SILICA DUSTS IS A MAJOR CAUSE OF L… | Department of Health and Human Services National Institutes of Health | 93.113 ENVIRONMENTAL HEALTH | TX-90 | 2024 | $211,206 |
ASST_NON_2345008_049 RAPID: INVESTIGATING RISK FOR ENVIRONMENTALLY ACQUIRED NONTUBERCULOUS MYCOBACTERIAL LUNG INFECTIONS IN THE WAKE OF THE LAHAINA, MAUI WILDFIRES -THE OBJECTIVE OF THIS RAPID RESPONS… | National Science Foundation National Science Foundation | 47.074 BIOLOGICAL SCIENCES | TYLER, TX-01 | 2024 | $200,000 |
ASST_NON_P425F205083_091 CARES ACT: HIGHER EDUCATION EMERGENCY RELIEF FUND | Department of Education Department of Education | 84.425 EDUCATION STABILIZATION FUND | TYLER, TX-01 | 2024 | $25,459 |
CONT_AWD_36C25725N0307_3600_36C25724D0066_3600 MICROBIOLOGY LAB SVC | Department of Veterans Affairs Department of Veterans Affairs | — | TYLER, TX-01 | 2025 | $13,120 |
CONT_AWD_36C25726N0323_3600_36C25724D0066_3600 MICROBIOLOGY LAB SVC | Department of Veterans Affairs Department of Veterans Affairs | — | TYLER, TX-01 | 2026 | $13,120 |
CONT_AWD_75N90024P00303_7529_-NONE-_-NONE- TESTING SERVICES NEEDED BY THE DEPARTMENT OF LABORATORY MEDICINE FOR PATIENT CARE. | Department of Health and Human Services National Institutes of Health | — | BETHESDA, MD-08 | 2024 | $11,000 |
ASST_NON_P425E201110_091 HIGHER EDUCATION EMERGENCY RELIEF FUND - IHES | Department of Education Department of Education | 84.425 EDUCATION STABILIZATION FUND | TYLER, TX-01 | 2024 | $9,312 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Industries
View All→Federal Programs (CFDA)
View All→12345678910
93.837 — CARDIOVASCULAR DISEASES RESEARCH$25.2M
93.262 — OCCUPATIONAL SAFETY AND HEALTH PROGRAM$25.1M
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$8.2M
93.211 — TELEHEALTH PROGRAMS$2.3M
93.310 — TRANS-NIH RESEARCH SUPPORT$2.1M
93.191 — GRADUATE PSYCHOLOGY EDUCATION$2.1M
81.108 — EPIDEMIOLOGY AND OTHER HEALTH STUDIES FINANCIAL ASSISTANCE PROGRAM$1.5M
12.420 — MILITARY MEDICAL RESEARCH AND DEVELOPMENT$1.3M
93.859 — BIOMEDICAL RESEARCH AND RESEARCH TRAINING$1.1M
93.912 — RURAL HEALTH CARE SERVICES OUTREACH, RURAL HEALTH NETWORK DEVELOPMENT AND SMALL HEALTH CARE PROVIDER QUALITY IMPROVEMENT$1.0M
Source: USAspending.gov · All Recipients · Texas